Epigral informs about press release

27 Jan 2025 Evaluate
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Epigral has informed that it enclosed a Press Release for Un-Audited Financial Results - Q3 FY2025. The said Press Release is also available at www.epigral.com in the Investor Relations section.

The above information is a part of company’s filings submitted to BSE.


Epigral Share Price

876.85 -8.60 (-0.97%)
11-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
BASF India 3464.95
Tata Chemicals 688.55
SRF 2487.10
Pidilite Inds. 1403.85
Deepak Nitrite 1488.70
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×